These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

670 related articles for article (PubMed ID: 21160474)

  • 1. Genetic variegation of clonal architecture and propagating cells in leukaemia.
    Anderson K; Lutz C; van Delft FW; Bateman CM; Guo Y; Colman SM; Kempski H; Moorman AV; Titley I; Swansbury J; Kearney L; Enver T; Greaves M
    Nature; 2011 Jan; 469(7330):356-61. PubMed ID: 21160474
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evolution of human BCR-ABL1 lymphoblastic leukaemia-initiating cells.
    Notta F; Mullighan CG; Wang JC; Poeppl A; Doulatov S; Phillips LA; Ma J; Minden MD; Downing JR; Dick JE
    Nature; 2011 Jan; 469(7330):362-7. PubMed ID: 21248843
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Heterogeneity and clonal evolution in pediatric ETV6-RUNX1(+) acute lymphoblastic leukemia by quantitative multigene fluorescence in situ hybridization].
    Zhang L; Hu LP; Liu XM; Guo Y; Yang WY; Zhang JY; Liu F; Liu TF; Wang SC; Chen XJ; Ruan M; Qi BQ; Chang LX; Chen YM; Zou Y; Zhu XF
    Zhonghua Xue Ye Xue Za Zhi; 2017 Jul; 38(7):586-591. PubMed ID: 28810325
    [No Abstract]   [Full Text] [Related]  

  • 4. Variegated clonality and rapid emergence of new molecular lesions in xenografts of acute lymphoblastic leukemia are associated with drug resistance.
    Nowak D; Liem NL; Mossner M; Klaumünzer M; Papa RA; Nowak V; Jann JC; Akagi T; Kawamata N; Okamoto R; Thoennissen NH; Kato M; Sanada M; Hofmann WK; Ogawa S; Marshall GM; Lock RB; Koeffler HP
    Exp Hematol; 2015 Jan; 43(1):32-43.e1-35. PubMed ID: 25450514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deep targeted sequencing in pediatric acute lymphoblastic leukemia unveils distinct mutational patterns between genetic subtypes and novel relapse-associated genes.
    Lindqvist CM; Lundmark A; Nordlund J; Freyhult E; Ekman D; Carlsson Almlöf J; Raine A; Övernäs E; Abrahamsson J; Frost BM; Grandér D; Heyman M; Palle J; Forestier E; Lönnerholm G; Berglund EC; Syvänen AC
    Oncotarget; 2016 Sep; 7(39):64071-64088. PubMed ID: 27590521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Copy number genome alterations are associated with treatment response and outcome in relapsed childhood ETV6/RUNX1-positive acute lymphoblastic leukemia.
    Bokemeyer A; Eckert C; Meyr F; Koerner G; von Stackelberg A; Ullmann R; Türkmen S; Henze G; Seeger K
    Haematologica; 2014 Apr; 99(4):706-14. PubMed ID: 24241490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Late relapses evolve from slow-responding subclones in t(12;21)-positive acute lymphoblastic leukemia: evidence for the persistence of a preleukemic clone.
    Konrad M; Metzler M; Panzer S; Ostreicher I; Peham M; Repp R; Haas OA; Gadner H; Panzer-Grumayer ER
    Blood; 2003 May; 101(9):3635-40. PubMed ID: 12506024
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic subclone architecture of tumor clone-initiating cells in colorectal cancer.
    Giessler KM; Kleinheinz K; Huebschmann D; Balasubramanian GP; Dubash TD; Dieter SM; Siegl C; Herbst F; Weber S; Hoffmann CM; Fronza R; Buchhalter I; Paramasivam N; Eils R; Schmidt M; von Kalle C; Schneider M; Ulrich A; Scholl C; Fröhling S; Weichert W; Brors B; Schlesner M; Ball CR; Glimm H
    J Exp Med; 2017 Jul; 214(7):2073-2088. PubMed ID: 28572216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clonal variation of the immunogenotype in relapsed ETV6/RUNX1-positive acute lymphoblastic leukemia indicates subclone formation during early stages of leukemia development.
    Peham M; Konrad M; Harbott J; König M; Haas OA; Panzer-Grümayer ER
    Genes Chromosomes Cancer; 2004 Feb; 39(2):156-60. PubMed ID: 14695996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clonal origins of ETV6-RUNX1⁺ acute lymphoblastic leukemia: studies in monozygotic twins.
    Alpar D; Wren D; Ermini L; Mansur MB; van Delft FW; Bateman CM; Titley I; Kearney L; Szczepanski T; Gonzalez D; Ford AM; Potter NE; Greaves M
    Leukemia; 2015 Apr; 29(4):839-46. PubMed ID: 25388957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathogenesis of ETV6/RUNX1-positive childhood acute lymphoblastic leukemia and mechanisms underlying its relapse.
    Sun C; Chang L; Zhu X
    Oncotarget; 2017 May; 8(21):35445-35459. PubMed ID: 28418909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ETV6/RUNX1-positive relapses evolve from an ancestral clone and frequently acquire deletions of genes implicated in glucocorticoid signaling.
    Kuster L; Grausenburger R; Fuka G; Kaindl U; Krapf G; Inthal A; Mann G; Kauer M; Rainer J; Kofler R; Hall A; Metzler M; Meyer LH; Meyer C; Harbott J; Marschalek R; Strehl S; Haas OA; Panzer-Grümayer R
    Blood; 2011 Mar; 117(9):2658-67. PubMed ID: 21224468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Darwin and evolutionary tales in leukemia. The Ham-Wasserman Lecture.
    Greaves M
    Hematology Am Soc Hematol Educ Program; 2009; ():3-12. PubMed ID: 20008176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clonal evolution of acute leukemia genomes.
    Jan M; Majeti R
    Oncogene; 2013 Jan; 32(2):135-40. PubMed ID: 22349821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Co-existence of multiple subclones in TEL-AML1 at diagnosis of acute lymphoblastic leukaemia in association with submicroscopic deletion of AML1.
    Rothman R; Trakhtenbrot L; Bielorai B; Izraeli S; Ishoev G; Amariglio N; Rechavi G; Toren A
    Br J Haematol; 2005 May; 129(4):491-8. PubMed ID: 15877731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clonal origins of relapse in ETV6-RUNX1 acute lymphoblastic leukemia.
    van Delft FW; Horsley S; Colman S; Anderson K; Bateman C; Kempski H; Zuna J; Eckert C; Saha V; Kearney L; Ford A; Greaves M
    Blood; 2011 Jun; 117(23):6247-54. PubMed ID: 21482711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High sensitivity and clonal stability of the genomic fusion as single marker for response monitoring in ETV6-RUNX1-positive acute lymphoblastic leukemia.
    Hoffmann J; Krumbholz M; Gutiérrez HP; Fillies M; Szymansky A; Bleckmann K; Zur Stadt U; Köhler R; Kuiper RP; Horstmann M; von Stackelberg A; Eckert C; Metzler M
    Pediatr Blood Cancer; 2019 Aug; 66(8):e27780. PubMed ID: 31034759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcome and Prognostic Factors for
    Lee JW; Kim SK; Jang PS; Chung NG; Jeong DC; Kim M; Cho B; Kim HK
    Cancer Res Treat; 2017 Apr; 49(2):446-453. PubMed ID: 27506214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The subclonal complexity of STIL-TAL1+ T-cell acute lymphoblastic leukaemia.
    Furness CL; Mansur MB; Weston VJ; Ermini L; van Delft FW; Jenkinson S; Gale R; Harrison CJ; Pombo-de-Oliveira MS; Sanchez-Martin M; Ferrando AA; Kearns P; Titley I; Ford AM; Potter NE; Greaves M
    Leukemia; 2018 Sep; 32(9):1984-1993. PubMed ID: 29556024
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic lesions in a preleukemic aplasia phase in a child with acute lymphoblastic leukemia.
    Horsley SW; Colman S; McKinley M; Bateman CM; Jenney M; Chaplin T; Young BD; Greaves M; Kearney L
    Genes Chromosomes Cancer; 2008 Apr; 47(4):333-40. PubMed ID: 18181181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.